The impact of comorbidities on surgical outcomes in Dupuytren’s disease
DOI:
https://doi.org/10.2340/jphs.v60.44800Keywords:
Dupuytren’s disease, palmar fasciectomy, comorbidities, recurrence rate, postoperative complicationsAbstract
Introduction: Dupuytren’s disease is a progressive fibroproliferative condition characterized by collagen deposition and the formation of fibrous cords along the palmar fascia and flexor tendons of the fingers. This study investigates the impact of comorbidities on surgical outcomes in patients undergoing palmar fasciectomy for Dupuytren’s disease.
Methods: A retrospective analysis was conducted on 109 patients who underwent palmar fasciectomy for Dupuytren’s disease between September 2006 and November 2023. Demographic data, associated comorbidities, and surgical techniques were recorded. Surgical outcomes were assessed using the Duruöz Hand Index. Clinical results were classified as excellent, good, fair, and poor.
Results: The cohort consisted mostly of men (94 men, 15 women), with an average age of 59.22 years. The most common comorbidities were smoking (55%), manual labor (41.3%), hypertension (38.5%), and diabetes (31.2%). Clinical outcomes were excellent or good in 82.5% of patients. The recurrence rate was 1.8%, and the incidence of permanent deformity was 4.5%. The complication rate was 11%, with malignancy detected in 11% of patients, most notably colon cancer (7 patients).
Conclusion: Palmar fasciectomy for Dupuytren’s disease is an effective surgical treatment with low recurrence and high success rates. However, comorbidities such as smoking and diabetes significantly impact surgical outcomes.
Downloads
References
Gelbard M, Rosenbloom J, Biology C, et al. Fibroproliferative disorders and diabetes: understanding the pathophysiologic relationship between Peyronie’s disease, Dupuytren disease and diabetes. Endocrinol Diabetes Metab. 2021; 4(2): e00195. https://doi.org/10.1002/edm2.195 DOI: https://doi.org/10.1002/edm2.195
Ruettermann M, Hermann RM, Khatib-Chahidi K, et al. Dupuytren’s disease—etiology and treatment. Dtsch Arztebl Int. 2021; 118(46): 781. https://doi.org/10.3238/arztebl.m2021.0325 DOI: https://doi.org/10.3238/arztebl.m2021.0325
Eaton C. Dupuytren disease. Tips and Tricks in Plastic Surgery. Vol. 1. Springer; 2021:703–741. https://doi.org/10.1007/978-3-030-78028-9_41 DOI: https://doi.org/10.1007/978-3-030-78028-9_41
Becker K, Tinschert S, Lienert A, et al. The importance of genetic susceptibility in Dupuytren’s disease. Clin Genet. 2015; 87(5): 483–487. https://doi.org/10.1111/cge.12410 DOI: https://doi.org/10.1111/cge.12410
Hindocha S, McGrouther DA, Bayat A. Epidemiological evaluation of Dupuytren’s disease incidence and prevalence rates in relation to etiology. Hand. 2009;4(3):256–269. https://doi.org/10.1007/s11552-008-9160-9 DOI: https://doi.org/10.1007/s11552-008-9160-9
Dias JJ, Aziz S. Fasciectomy for Dupuytren contracture. Hand Clin. 2018;34(3):351–366. https://doi.org/10.1016/j.hcl.2018.04.002 DOI: https://doi.org/10.1016/j.hcl.2018.04.002
Eberlin KR, Mudgal CS. Complications of treatment for Dupuytren disease. Hand Clin. 2018; 34(3): 387–394. https://doi.org/10.1016/j.hcl.2018.03.007 DOI: https://doi.org/10.1016/j.hcl.2018.03.007
Smith AC. Diagnosis and indications for surgical treatment. Hand Clin. 1991; 7(4): 635–642. https://doi.org/10.1016/S0749-0712(21)00900-8 DOI: https://doi.org/10.1016/S0749-0712(21)00900-8
Khan P, Iqbal S, Zaroo I, et al. Surgical treatment of Dupuytren’s contracture; results and complications of surgery: our experience. J Hand Microsurg. 2016; 02(02): 62–66. https://doi.org/10.1007/s12593-010-0019-2 DOI: https://doi.org/10.1007/s12593-010-0019-2
Gürçay E, Alanoğlu E, Tuncay R, et al. Romatoid Elde Duruöz El Skalasının ve Kavrama Beceri Testinin Değerlendirilmesi. Turkiye Klinikleri J Phys.Med. Rehabil. 2004; 4(1): 1–6 [Internet]. [cited 2024 Dec 29]. Available from: https://www.turkiyeklinikleri.com/article/en-romatoid-elde-duruoz-el-skalasinin-ve-kavrama-beceri-testinin-degerlendirilmesi-31288.html
Hartmann J. Dupuytren’ s disease: ethiopathogenesis, clinical manifestation, types of surgery, surgery vs conservative treatment–literature review [Internet]. 2024 [cited 2024 Dec 29]. Available from: https://epublications.vu.lt/object/elaba:210544342/
Cevik J, Rajaram R, Pollock M, et al. Collagenase clostridium histolyticum for Dupuytren’s disease: a comprehensive systematic review and comparative analysis against percutaneous needle aponeurotomy and limited fasciectomy. J Plast Surg Hand Surg. 2025;60:27–34. https://doi.org/10.2340/jphs.v60.42750 DOI: https://doi.org/10.2340/jphs.v60.42750
Eckerdal D, Nivestam A, Dahlin LB. Surgical treatment of Dupuytren’s disease – outcome and health economy in relation to smoking and diabetes. BMC Musculoskelet Disord. 2014; 15(1): 1–8. https://doi.org/10.1186/1471-2474-15-117 DOI: https://doi.org/10.1186/1471-2474-15-117
Wang Z, Wang Z, Yan Z, et al. Smoking, alcohol consumption and risk of Dupuytren’s disease: a Mendelian randomization study. BMC Med Genom. 2023; 16(1): 1–8. https://doi.org/10.1186/s12920-023-01650-4 DOI: https://doi.org/10.1186/s12920-023-01650-4
Zachrisson A, Sörensen AI, Strömberg J. Needle fasciotomy for Dupuytren’s contracture – a prospective cohort study of 58 fingers with a median follow-up of 6.5 years. J Plast Surg Hand Surg. 2020; 54(2): 89–93. https://doi.org/10.1080/2000656X.2019.1693391 DOI: https://doi.org/10.1080/2000656X.2019.1693391
Kuo RYL, Ng M, Prieto-Alhambra D, et al. Dupuytren’s disease predicts increased all-cause and cancer-specific mortality: analysis of a large cohort from the U.K. Clinical Practice Research Datalink. Plast Reconstr Surg. 2020; 145(3): 574E–582E. https://doi.org/10.1097/PRS.0000000000006551 DOI: https://doi.org/10.1097/PRS.0000000000006551
Kose AA, Demirkan B, Sevencan A, et al. Comorbidity analysis of Turkish patients operated for Dupuytren’s contracture in a university hospital. Turk J Plastic Surg. 2022; 30(4): 102–107. https://doi.org/10.4103/tjps.tjps_32_22 DOI: https://doi.org/10.4103/tjps.tjps_32_22
Żyluk A. Recurrence of Dupuytren’s disease following surgery – an analysis of the causes and incidence. Pomeranian J Life Sci. 2020; 66(4): 6–8. https://doi.org/10.21164/pomjlifesci.743 DOI: https://doi.org/10.21164/pomjlifesci.743
Radhamony NG, Nair RR, Sreenivasan S, et al. Residual deformity versus recurrence following Dupuytren’s palmar fasciectomy – a long term follow-up of 142 cases. Ann Med Surg. 2022; 73: 103224. https://doi.org/10.1016/j.amsu.2021.103224 DOI: https://doi.org/10.1016/j.amsu.2021.103224
Cox R, McCann A, Cross S, et al. The lived experience and occupational impact of individuals with Dupuytren’s disease: a scoping review. Int J Ther Rehabil. 2022;29(11):1–15. DOI: https://doi.org/10.12968/ijtr.2021.0122
Demmer W, Sorg H, Steiert A, et al. Wound healing and therapy in soft tissue defects of the hand and foot from a surgical point of view. Med Sci. 2021; 9(4): 71. https://doi.org/10.3390/medsci9040071 DOI: https://doi.org/10.3390/medsci9040071
Karam M, Kahlar N, Abul A, et al. Comparison of hand therapy with or without splinting postfasciectomy for Dupuytren’s contracture: systematic review and meta-analysis. J Hand Microsurg. 2023; 14(4): 308–314. https://doi.org/10.1055/s-0041-1725221 DOI: https://doi.org/10.1055/s-0041-1725221
Pashmdarfard M, Azad A, Amini M, et al. The effect of splinting after Dupuytren’s contracture operation: a systematic review. Iranian Rehabil J. 2019; 17(4): 297–304. https://doi.org/10.32598/irj.17.4.297 DOI: https://doi.org/10.32598/irj.17.4.297
Kitridis D, Karamitsou P, Giannaros I, et al. Dupuytren’s disease: limited fasciectomy, night splinting, and hand exercises—long-term results. Eur J Orthopaed Surg Traumatol. 2019; 29(2): 349–355. https://doi.org/10.1007/s00590-018-2340-6 DOI: https://doi.org/10.1007/s00590-018-2340-6
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Mehmet Yalçın, Yusuf Kıratlıoğlu, Melih Kıryaman, Uğur Bezirgan
This work is licensed under a Creative Commons Attribution 4.0 International License.
Acta Chirurgica Scandinavica Society owns the copyright for all material published until Volume 57 (2023) unless otherwise specified. As from 2024 all published articles, unless otherwise specified, are published under CC-BY licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, with the condition of proper attribution to the original work.
